01 3Pfizer Canada ULC
01 32473026
01 3PALBOCICLIB
01 3CAPSULE
01 32023-01-10
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Brand Name : IBRANCE
Patent Number : 2473026
Filing Date : 2003-01-10
Strength per Unit : 75 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Brand Name : IBRANCE
Patent Number : 2473026
Filing Date : 2003-01-10
Strength per Unit : 100 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
Brand Name : IBRANCE
Patent Number : 2473026
Filing Date : 2003-01-10
Strength per Unit : 125 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-01-10
Date Granted : 2011-05-03
LOOKING FOR A SUPPLIER?
